Collyar D E
Patient Advocates in Research, the Clinical Trials Information Project, and the University of California San Francisco Breast Specialized Program of Research Excellence (SPORE) Advocacy Core, USA.
J Clin Oncol. 2001 Sep 15;19(18 Suppl):101S-105S.
The 2001 American Society of Clinical Oncology (ASCO) International Symposium, Breast Cancer: A Global Perspective, was conducted by members of the ASCO International Committee and additional speakers from around the world. An interactive format was chosen to: (1) learn how patterns of incidence, epidemiology, and causal biology relate to breast cancer around the world; (2) discuss the challenges in screening, diagnosis, and treatment of breast cancer, as well as its socioeconomic impact in various regions; (3) describe international differences in approach to and management of advanced breast cancer; and (4) discuss treatment in terms of hormone response, clinical research, and drug metabolism. After a brief introduction, each speaker gave an overview of breast cancer challenges and issues in their country, and discussed how the following case might be diagnosed and treated: A 44-year-old mother who presents with a finding of a painless breast lump and no prior history of breast masses, trauma, or surgery. Comments from a patient perspective were then presented, followed by a panel discussion and closing remarks. Co-chairs of this Symposium included Deborah Collyar (President, PAIR-Patient Advocates in Research) and Elizabeth Eisenhauer, MD (Director, Investigational New Drug Program, National Cancer Institute of Canada Clinical Trials Group). Speakers included Gilberto Schwartsmann, MD (South America), Monica Morrow, MD (North America), Daniel Vorobiof, MD (South Africa), Rakesh Chopra, MD (India), Klaus Hoeffken, MD (Eastern Europe), Russell Basser, MD (Australia), Susan Matsuko Shinigawa (patient perspective), and Larry Norton, MD (closing remarks).
2001年美国临床肿瘤学会(ASCO)国际研讨会“乳腺癌:全球视角”由ASCO国际委员会成员以及来自世界各地的其他演讲者共同举办。会议采用了互动形式,旨在:(1)了解全球乳腺癌的发病率模式、流行病学及病因生物学之间的关系;(2)讨论乳腺癌筛查、诊断和治疗方面的挑战,以及其在不同地区的社会经济影响;(3)描述晚期乳腺癌治疗方法和管理方面的国际差异;(4)从激素反应、临床研究和药物代谢方面讨论治疗情况。简短介绍之后,每位演讲者概述了本国乳腺癌面临的挑战和问题,并讨论了以下病例的诊断和治疗方法:一位44岁的母亲,乳房发现无痛肿块,既往无乳房肿块、外伤或手术史。随后展示了患者视角的评论,接着是小组讨论和闭幕致辞。本次研讨会的联合主席包括黛博拉·科利亚尔(研究中患者权益倡导者配对组织主席)和伊丽莎白·艾森豪尔医学博士(加拿大国家癌症研究所临床试验组研究性新药项目主任)。演讲者包括吉尔伯托·施瓦茨曼医学博士(南美洲)、莫妮卡·莫罗医学博士(北美洲)、丹尼尔·沃罗比约夫医学博士(南非)、拉凯什·乔普拉医学博士(印度)、克劳斯·赫夫肯医学博士(东欧)、拉塞尔·巴塞尔医学博士(澳大利亚)、苏珊·松子·筱川(患者视角)以及拉里·诺顿医学博士(闭幕致辞)。